Driving Efficiency in Lentivirus Manufacturing with Fixed-Bed Bioreactors
Lentiviral vectors (LVs) have emerged as a cornerstone of gene therapy, enabling transformative treatments ranging from ex vivo applications like CAR T to promising in vivo delivery approaches. Yet, despite their potential, LV production remains ... Continued
